FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Lannett Company, Inc.)

View source ↗

Summary

The FDA approved a supplemental application to allow Lannett Company, Inc. to market a generic Montelukast Sodium product (ANDA 200405).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Seasonal Allergic Rhinitis

Drugs mentioned

• Montelukast Sodium (Montelukast Sodium)

Snippet

SUPPL AP for MONTELUKAST SODIUM (MONTELUKAST SODIUM)